These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 7882634)

  • 1. Pefloxacin clinical pharmacokinetics.
    Bressolle F; Gonçalves F; Gouby A; Galtier M
    Clin Pharmacokinet; 1994 Dec; 27(6):418-46. PubMed ID: 7882634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic disposition of quinolones in human body fluids and tissues.
    Sörgel F; Jaehde U; Naber K; Stephan U
    Clin Pharmacokinet; 1989; 16 Suppl 1():5-24. PubMed ID: 2653696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics and tissue penetration of the fluoroquinolones.
    Bergeron MG
    Clin Invest Med; 1989 Feb; 12(1):20-7. PubMed ID: 2920479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple-dose pharmacokinetics of pefloxacin in patients with hepatocellular deficiency.
    Galtier M; Bressolle F; de la Coussaye JE; Gomeni R; Joubert P; Gény F; Dubois A; Raffanel C; Saissi G; Eledjam JJ
    Clin Pharmacokinet; 1993 Nov; 25(5):415-23. PubMed ID: 8287635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and tissue distribution of intravenous pefloxacin for antibiotic prophylaxis in biliary surgery.
    Gascón AR; Campo E; Olea E; Hernández RM; Calvo B; Errasti J; Pedraz JL
    Biopharm Drug Dispos; 2002 Oct; 23(7):293-300. PubMed ID: 12355580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of sparfloxacin.
    Shimada J; Nogita T; Ishibashi Y
    Clin Pharmacokinet; 1993 Nov; 25(5):358-69. PubMed ID: 8287631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and tissue residues of pefloxacin and its metabolite norfloxacin in broiler chickens.
    Pant S; Rao GS; Sastry KV; Tripathi HC; Jagmohan ; Malik JK
    Br Poult Sci; 2005 Oct; 46(5):615-20. PubMed ID: 16359117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some pharmacokinetic parameters of pefloxacin in lactating goats.
    Abd El-Aty AM; Goudah A
    Vet Res Commun; 2002 Oct; 26(7):553-61. PubMed ID: 12416870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and tissue penetration of orally administered pefloxacin.
    Webberley JM; Andrews JM; Ashby JP; McLeod A; Wise R
    Eur J Clin Microbiol; 1987 Oct; 6(5):521-4. PubMed ID: 3481335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral pharmacokinetics and ascitic fluid penetration of pefloxacin in cirrhosis.
    Cardey J; Silvain C; Bouquet S; Breux JP; Becq-Giraudon B; Fourtillan JP; Beauchant M
    Eur J Clin Pharmacol; 1987; 33(5):469-72. PubMed ID: 3480805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Report: pharmacokinetic and drug interaction studies of pefloxacin with paracetamol (NNAID) in healthy volunteers in Pakistan.
    Gauhar S; Ali SA; Naqvi SB; Shoaib MH
    Pak J Pharm Sci; 2014 Mar; 27(2):389-95. PubMed ID: 24577931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration-time courses of pefloxacin in plasma and milk of lactating she-camels (Camelus dromedarius).
    Goudah A; Shah SS; Shin HC; Chang BJ; Shim JH; Abd El-Aty AM
    Berl Munch Tierarztl Wochenschr; 2008; 121(11-12):432-9. PubMed ID: 19086693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Bayesian estimation to discriminate subpopulations of patients with altered pharmacokinetics using fragmentary data: a pilot study with pefloxacin.
    Bruno R; Rosier P; Iliadis A; Le Roux Y; Montay G; Frydman A; Gaillot J
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():338-45. PubMed ID: 1820906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diffusion of pefloxacin in the aqueous humor and crystalline lens after repeated oral administration in man].
    Salvanet-Bouccara A; Montay G; Fisch A; Forestier F; Meziane D; Lafaix C; Prieur MB
    J Fr Ophtalmol; 1991; 14(4):260-4. PubMed ID: 1955654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some plasma and saliva pharmacokinetics parameters of rifampicin in the presence of pefloxacin.
    Orisakwe OE; Akunyili DN; Agbasi PU; Ezejiofor NA
    Am J Ther; 2004; 11(4):283-7. PubMed ID: 15266220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of newer fluoroquinolones.
    Stein GE
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S19-24. PubMed ID: 8953102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intraocular penetration of pefloxacin in man and rabbit. The aqueous humor and vitreous body].
    Denis F; Mounier M; Adenis JP
    Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):772-6. PubMed ID: 3309813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone antibacterials.
    Aminimanizani A; Beringer P; Jelliffe R
    Clin Pharmacokinet; 2001; 40(3):169-87. PubMed ID: 11327197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of fluoroquinolones in hepatic failure.
    Montay G; Gaillot J
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():61-7. PubMed ID: 2258353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of intravenously administered pefloxacin in the prostate; perspectives for its application in surgical prophylaxis.
    Giannopoulos A; Koratzanis G; Giamarellos-Bourboulis EJ; Stinios I; Chrisofos M; Giannopoulou M; Giamarellou H
    Int J Antimicrob Agents; 2001 Mar; 17(3):221-4. PubMed ID: 11282268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.